Viewing Study NCT03620318


Ignite Creation Date: 2025-12-25 @ 4:41 AM
Ignite Modification Date: 2026-03-05 @ 4:55 PM
Study NCT ID: NCT03620318
Status: AVAILABLE
Last Update Posted: 2024-08-09
First Post: 2018-08-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Individual Patient Compassionate Use of Crenolanib
Sponsor: Arog Pharmaceuticals, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ARO-EAP
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators